Built by operators.
Validated by scientists.

Zach earned his BS from the US Naval Academy and served 14 years with the SEAL Teams before leaving Jefferson Medical School to co-found MATBOCK — a successful defense-focused startup he helped grow and exit. His combination of special operations experience and entrepreneurial track record makes him uniquely suited to lead Aceso Plasma through its development and commercialization journey. Zach understands firsthand the wound care challenges that military medics face in austere environments — and built Aceso Plasma to solve them.

Sean graduated from VMI and served with the SEAL Teams before becoming a serial entrepreneur with four company launches and two successful exits to his name. As co-founder of MATBOCK alongside Zach, he developed deep experience building defense-focused companies from the ground up. Sean brings the strategic vision and investor relationships needed to scale Aceso Plasma from an investigational device into a commercially deployed medical technology — across both the military and civilian healthcare markets.

Craig brings over 25 years of medical device commercialization experience, including senior roles at Guidant Corporation and NICO Corporation where he led teams through FDA clearance, market launch, and scale. He served seven years as a Marine Infantry Officer before transitioning to healthcare — co-founding wellness and telehealth startups and consulting for hospitals and EHR vendors. Craig's rare combination of operational military discipline and deep medtech industry expertise gives Aceso Plasma the commercialization leadership that most early-stage medical device companies lack.

Dr. Kuo is a Full Professor at NYU Tandon School of Engineering with over 40 years of research in plasma physics and its medical and aerospace applications. He has completed 17 DoD and NASA grants, published over 190 journal papers and 80 proceedings articles, and holds five US patents and two foreign patents. Dr. Kuo pioneered the air plasma technology that forms the scientific foundation of Aceso Plasma — with peer-reviewed publications in IEEE Transactions on Plasma Science and the Journal of Biomedical Science and Engineering validating the mechanism of action behind the device.

Dr. Kenneth "Trip" Johnson is a retired physician from the Joint Medical Augmentation Unit (JMAU) — one of the most specialized military medical units in the US military — bringing elite special operations medical experience directly to Aceso Plasma's clinical leadership. As CMO, Dr. Johnson chairs the company's Physician Advisory Board and guides clinical strategy, regulatory positioning, and the communication of unmet needs in wound care that Aceso is designed to address. His background in military medicine and special operations gives Aceso direct insight into the environments and challenges the device was built to solve.